Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person UniProt:Q8K348 Acvr1c

Class:IdReferenceGeneProduct:217971
_chainChangeLogsignal peptide:1-25 added on Fri February 6 2015;chain:26-493 added on Fri February 6 2015
_displayNameUniProt:Q8K348 Acvr1c
_timestamp2025-08-15 22:05:57
chainsignal peptide:1-25
chain:26-493
checksumCB9BE5E368CA2D2F
commentFUNCTION Serine/threonine protein kinase which forms a receptor complex on ligand binding. The receptor complex consists of 2 type II and 2 type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators, SMAD2 and SMAD3. Receptor for activin AB, activin B, activin E and NODAL. Upon NODAL binding, activation results in increased apoptosis and reduced proliferation through suppression of AKT signaling and the activation of Smad2-dependent signaling pathway in pancreatic beta-cells, trophoblasts, epithelial or neuronal cells (PubMed:18480258, PubMed:36403856). Acts as a positive regulator for macrophage activation partially through down-regulation of PPARG expression (PubMed:32641645).CATALYTIC ACTIVITY L-threonyl-[receptor-protein] + ATP = O-phospho-L-threonyl-[receptor-protein] + ADP + H(+)CATALYTIC ACTIVITY L-seryl-[receptor-protein] + ATP = O-phospho-L-seryl-[receptor-protein] + ADP + H(+)COFACTOR Binds the type 2 receptor protein ACVR2A.SUBCELLULAR LOCATION Expressed in interdigital regions in developing limb buds.INDUCTION Upon oxidized low-density lipoprotein stimulation in macrophages.DISRUPTION PHENOTYPE Acvr1c mutant embryos develop normally, with none of the known NODAL-related phenotypes found in these mice, suggesting that Acvr1c is not an obligatory component of the NODAL signaling pathway, at least during early development (PubMed:15485907). Acvr1c deleted mice however develop age-dependent metabolic syndromes, including progressive hyperinsulinemia, reduced insulin sensitivity, liver steatosis, impaired glucose tolerance and pancreatic island enlargement (PubMed:18480258).SIMILARITY Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily.
created[InstanceEdit:217385] Schmidt, EE, 2008-03-27 06:23:53
descriptionrecommendedName: Activin receptor type-1C ecNumber: 2.7.11.30 alternativeName: Activin receptor type IC shortName: ACTR-IC alternativeName: Activin receptor-like kinase 7 shortName: ALK-7
geneNameAcvr1c
Alk7
identifierQ8K348
isSequenceChangedFALSE
keywordApoptosis
ATP-binding
Cell membrane
Kinase
Magnesium
Manganese
Membrane
Metal-binding
Nucleotide-binding
Receptor
Reference proteome
Serine/threonine-protein kinase
Signal
Transferase
Transmembrane
Transmembrane helix
modified[InstanceEdit:354386] Schmidt, EE, 2008-06-18 04:45:12
[InstanceEdit:384350] Kanapin, AA, 2008-11-26 14:00:39
[InstanceEdit:392885] Kanapin, AA, 2009-03-09 12:07:18
[InstanceEdit:400710] Schmidt, EE, 2009-03-25 05:33:35
[InstanceEdit:423310] Kanapin, AA
[InstanceEdit:435478] Kanapin, AA
[InstanceEdit:435871] Kanapin, AA
[InstanceEdit:447347] Kanapin, AA
[InstanceEdit:525883] Kanapin, AA
[InstanceEdit:613449] Kanapin, AA
[InstanceEdit:797602] Kanapin, AA
[InstanceEdit:937368] Yung, CK
[InstanceEdit:1042053] Yung, CK
[InstanceEdit:1220657] Yung, CK
[InstanceEdit:1300696] Yung, CK
[InstanceEdit:1301627] Yung, CK
[InstanceEdit:1551960] Weiser, JD
[InstanceEdit:1995863] Weiser, JD
[InstanceEdit:2132304] Weiser, JD
[InstanceEdit:2265580] Weiser, JD
[InstanceEdit:5433710] Weiser, JD
[InstanceEdit:5618415] Weiser, JD
[InstanceEdit:5634237] Weiser, JD
[InstanceEdit:5673015] Weiser, JD
[InstanceEdit:9037114] Weiser, JD
[InstanceEdit:9637257] Weiser, JD
[InstanceEdit:9676415] Weiser, JD
[InstanceEdit:9852000] Weiser, Joel, 2023-11-03
[InstanceEdit:9939033] Weiser, Joel, 2025-02-21
[InstanceEdit:9963647] Weiser, Joel, 2025-08-15
nameAcvr1c
referenceDatabase[ReferenceDatabase:2] UniProt
secondaryIdentifierACV1C_MOUSE
A2AJR4
sequenceLength493
species[Species:48892] Mus musculus
(referenceEntity)[EntityWithAccessionedSequence:1225916] Acvr1c [plasma membrane] [Mus musculus]
[EntityWithAccessionedSequence:2470468] p-Acvr1c [plasma membrane] [Mus musculus]
[Change default viewing format]
No pathways have been reviewed or authored by UniProt:Q8K348 Acvr1c (217971)